Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

NET 2Endocrine 2Sarcoma 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Lung Neoplasms 5Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Tongue Neoplasms 2Rectal Neoplasms 2Neuroendocrine Tumors 2Melanoma 2Lymphoma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Neuroendocrine 2Venous Thrombosis 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Sarcoma 1Salivary Gland Neoplasms 1Respiration Disorders 1Recurrence 1Pulmonary Embolism 1Pituitary Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mouth Neoplasms 1Lung Diseases 1Liver Diseases 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Cisplatin 3surufatinib 2sintilimab 2lutetium Lu 177 dotatate 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Fluorodeoxyglucose F18 2Everolimus 2toripalimab 1copper dotatate CU-64 1Radiopharmaceuticals 1PE regimen 1Nivolumab 1Interferon-alpha 1IFL protocol 1Gemcitabine 1Fluorouracil 1Etoposide 1EC regimen 1Copper 1Carboplatin 1Capecitabine 1Bevacizumab 164Cu-DOTATATE 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Neuroendocrine × Fluorodeoxyglucose F18 × Clear all
NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Rigshospitalet, Denmark

Phase 2 Unknown
15 enrolled
BreastEndocrineLymphoidNETSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT05709171 2023-11-22

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Rigshospitalet, Denmark

Phase 2 Unknown
200 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡